Literature DB >> 24284505

A history of surgery for locally-advanced (T4) cancer of the thoracic esophagus in Japan and a personal perspective.

Hiromasa Fujita1.   

Abstract

The history of esophageal surgery in Japan can be divided into three periods, an era of safety from 1930 to 1980, an era of radicality from 1980 to 2000, and the era of quality of life (QOL) from 2000 to the present. The treatment for T4 cancers of the thoracic esophagus has also changed over time from preoperative radiotherapy, combined resection of the neighboring organs with esophagectomy, and to definitive chemoradiotherapy (dCRT) with salvage surgery. At present, almost all patients with an unresectable T4 esophageal cancer receives dCRT. However, there are many patients with a residual or recurrent tumor after dCRT. Salvage surgery for such patients often results in incomplete resection of the tumor because the tumor involves the trachea and/or aorta. New techniques to enable the resection of such neighboring organs even during salvage surgery are needed. In the future, the mainstay of treatment for esophageal cancer will be CRT with the foreseeable progress in new drugs and new techniques of radiotherapy. Surgery will be indicated for a local failure after CRT, while combined resection of the neighboring organs will be necessary to treat a local failure after CRT for T4 cancers. New surgical techniques have to be developed through some application of new devices and equipment.

Entities:  

Mesh:

Year:  2013        PMID: 24284505     DOI: 10.5761/atcs.ra.13-00085

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  6 in total

Review 1.  Surgical strategies for treatment of clinical T4 esophageal cancer in Japan.

Authors:  Kazuhiko Yamada; Kyoko Nohara; Naoki Enomoto; Hitomi Wake; Syusuke Yagi; Masayoshi Terayama; Daiki Kato; Chizu Yokoi; Yasushi Kojima; Hidetsugu Nakayama; Norihiro Kokudo
Journal:  Glob Health Med       Date:  2021-12-31

2.  Salvage esophagectomy combined with partial aortic wall resection following thoracic endovascular aortic repair.

Authors:  Masanobu Nakajima; Hiroto Muroi; Maiko Kikuchi; Satoru Yamaguchi; Kinro Sasaki; Takashi Tsuchioka; Yusuke Takei; Ikuko Shibasaki; Hirotsugu Fukuda; Hiroyuki Kato
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-09-15

3.  Salvage esophagectomy under bilateral thoracotomy after definitive chemoradiotherapy for aorta T4 thoracic esophageal squamous cell carcinoma: Report of a case.

Authors:  Yushi Nagaki; Yusuke Sato; Satoru Motoyama; Kei Yoshino; Tomohiko Sasaki; Akiyuki Wakita; Kazuhiro Imai; Hajime Saito; Yoshihiro Minamiya
Journal:  Int J Surg Case Rep       Date:  2015-01-14

4.  Risk factors for esophageal fistula in patients with locally advanced esophageal carcinoma receiving chemoradiotherapy.

Authors:  Yang Zhang; Zongjuan Li; Wei Zhang; Wei Chen; Yipeng Song
Journal:  Onco Targets Ther       Date:  2018-04-23       Impact factor: 4.147

5.  Long-term survival after esophagectomy with distal pancreatectomy for locally advanced esophageal cancer with pancreatic invasion: a case report.

Authors:  Yoshiki Kaneko; Katsuji Hisakura; Koichi Ogawa; Yoshimasa Akashi; Yusuke Ohara; Yohei Owada; Tsuyoshi Enomoto; Kinji Furuya; Shoko Moue; Manami Doi; Kazuhiro Takahashi; Osamu Shimomura; Shinji Hashimoto; Noriaki Sakamoto; Tsunehiko Maruyama; Tatsuya Oda
Journal:  Surg Case Rep       Date:  2021-12-14

6.  Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303.

Authors:  Takahiro Tsushima; Junki Mizusawa; Kazuki Sudo; Yoshitaka Honma; Ken Kato; Hiroyasu Igaki; Yasuhiro Tsubosa; Masayuki Shinoda; Kenichi Nakamura; Haruhiko Fukuda; Yuko Kitagawa
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.